Matinas BioPharma Holdings Inc (NYSE:MTNB) was the target of a large decrease in short interest in July. As of July 14th, there was short interest totalling 4,176,369 shares, a decrease of 12.2% from the June 30th total of 4,755,219 shares. Based on an average daily volume of 388,851 shares, the days-to-cover ratio is currently 10.7 days. Currently, 6.3% of the company’s stock are sold short.
Shares of Matinas BioPharma Holdings (NYSE MTNB) traded up 14.40% during midday trading on Tuesday, hitting $1.43. 640,149 shares of the stock were exchanged. The stock’s 50 day moving average is $1.79 and its 200 day moving average is $2.59. The firm’s market cap is $130.70 million. Matinas BioPharma Holdings has a 12-month low of $0.63 and a 12-month high of $3.99.
Matinas BioPharma Holdings Company Profile
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections.
Receive News & Ratings for Matinas BioPharma Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.
